Physician profile
Elizabeth A Mackey
NPI 1912923814
$244.43
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.07 · 2020: $84.84 · 2021: $82.86 · 2022: $52.66.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $121.18 | 2020-2022 | |
| Medline Industries LP | $22.29 | 2021 | |
| Tactile Systems Technology INC | $20.68 | 2021 | |
| Merck Sharp & Dohme LLC | $18.36 | 2020 | |
| Smith+Nephew, INC. | $14.45 | 2021 | |
| Shire North American Group INC | $13.14 | 2019 | |
| Novo Nordisk INC | $12.10 | 2020 | |
| Amarin Pharma, INC. | $11.30 | 2020 | |
| Lilly USA, LLC | $10.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.